BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Transl Med. Nov 28, 2026; 12(4): 127250
Published online Nov 28, 2026. doi: 10.5528/wjtm.127250
Figure 1
Figure 1 Iron-inflammation-erythropoiesis control of fibroblast growth factor 23 production and processing. Iron deficiency, inflammation, and erythropoietic stress increase fibroblast growth factor 23 production, whereas proteolytic processing determines the balance between intact fibroblast growth factor 23 and C-terminal fragments. FGF23: Fibroblast growth factor 23; HIF: Hypoxia-inducible factor; IL-6: Interleukin-6; TNFα: Tumor necrosis factor alpha; EPO: Erythropoietin; FGFR4: Fibroblast growth factor receptor 4; HF: Heart failure.


Write to the Help Desk